Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
for Chronic Lymphocytic Leukemia (CLL)
4 locations incl. Scarborough
Sponsor: Dana-Farber Cancer Institute
Sex: All·Age: 18+
Code: NCT05168930·Phase 2·Recruiting·Listed Dec 2021
South Shore Hospital
Clinical research site in South Weymouth, Massachusetts · 55 FOGG RD, SOUTH WEYMOUTH, MA 02190-2432 · (781) 624-8000
As of July 2026, 1 paid clinical trial is recruiting at South Shore Hospital in South Weymouth, Massachusetts. Active studies at this site cover conditions such as Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at South Shore Hospital (1)
More research sites in South Weymouth
- Dana-Farber/Brigham and Women's Cancer Center at South Shore (10 trials)
- Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) in Clinical Affiliation with South Shore Hospital (2 trials)
- DF/BWCC in Clinical Affiliation with South Shore Hospital (1 trial)
- Dana-Farber Brigham Cancer Center at South Shore Health (1 trial)
- Dana-Farber Brigham Cancer Center, South Shore Hospital (1 trial)
- Dana-Farber Cancer Institute South Shore (1 trial)
Explore more
Paid clinical trials in South Weymouth, MA · Massachusetts clinical trials